Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage.
Le Rouzic, E., Bonnard, D., Chasset, S., Bruneau, J.M., Chevreuil, F., Le Strat, F., Nguyen, J., Beauvoir, R., Amadori, C., Brias, J., Vomscheid, S., Eiler, S., Levy, N., Delelis, O., Deprez, E., Saib, A., Zamborlini, A., Emiliani, S., Ruff, M., Ledoussal, B., Moreau, F., Benarous, R.(2013) Retrovirology 10: 144-144
- PubMed: 24261564 
- DOI: https://doi.org/10.1186/1742-4690-10-144
- Primary Citation of Related Structures:  
4LH4, 4LH5 - PubMed Abstract: 
LEDGF/p75 (LEDGF) is the main cellular cofactor of HIV-1 integrase (IN). It acts as a tethering factor for IN, and targets the integration of HIV in actively transcribed gene regions of chromatin. A recently developed class of IN allosteric inhibitors can inhibit the LEDGF-IN interaction.
Organizational Affiliation: 
Biodim Mutabilis, Romainville 93230, France. richard.benarous@mutabilis.fr.